β–adrenergic blockade, a renal perspective

dc.contributor.authorMcLigeyo, Seth
dc.contributor.otherAssociation of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)en
dc.date.accessioned2007-11-19T22:54:54Z
dc.date.available2007-11-19T22:54:54Z
dc.date.issued2007
dc.description.abstractCarvedilol • Third generation β–blocker (both β1and β2) • Possesses α1–adrenergic blocking properties. • β: αblocking ratio 7:1 to 3:1 • Antioxidant • Calcium antagonisten
dc.identifier.urihttps://hdl.handle.net/1805/1172
dc.languageEnglishen
dc.language.isoenen
dc.publisherAssociation of Kenya Physiciansen
dc.subjectcarvedilolen
dc.subjectmyocardial functionen
dc.subjectβ-blockersen
dc.subjecthypertensionen
dc.subjectanti-inflammatoryen
dc.subjectdiabetesen
dc.subjectGEMINI trialen
dc.subject.meshAdrenergic beta-Antagonists
dc.subject.meshcarvedilol
dc.subject.meshnebivolol
dc.subject.meshDiabetes Mellitus drug therapy
dc.titleβ–adrenergic blockade, a renal perspectiveen
dc.typePresentationen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Beta blockade a renal perspective Prof Mccligeyo.pdf
Size:
6.2 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.93 KB
Format:
Item-specific license agreed upon to submission
Description: